1-(2-Chloro-benzyl)-6-[5-(4-ethyl-piperazine-1-sulfonyl)-2-propoxy-phenyl]-1,7-dihydro-imidazo[4,5-g]quinazolin-8-one

ID: ALA146373

Chembl Id: CHEMBL146373

PubChem CID: 135485841

Max Phase: Preclinical

Molecular Formula: C31H33ClN6O4S

Molecular Weight: 621.16

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOc1ccc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc(O)c2cc3c(cc2n1)ncn3Cc1ccccc1Cl

Standard InChI:  InChI=1S/C31H33ClN6O4S/c1-3-15-42-29-10-9-22(43(40,41)38-13-11-36(4-2)12-14-38)16-24(29)30-34-26-18-27-28(17-23(26)31(39)35-30)37(20-33-27)19-21-7-5-6-8-25(21)32/h5-10,16-18,20H,3-4,11-15,19H2,1-2H3,(H,34,35,39)

Standard InChI Key:  AVMVSXLWQSNQCT-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA146373

    ---

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 3 and 5 (PDE3 and PDE5) (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 4 and 5 (PDE4 and PDE5) (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 621.16Molecular Weight (Monoisotopic): 620.1973AlogP: 5.17#Rotatable Bonds: 9
Polar Surface Area: 113.68Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.39CX Basic pKa: 6.20CX LogP: 5.92CX LogD: 5.89
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.24Np Likeness Score: -1.87

References

1. Rotella DP, Sun Z, Zhu Y, Krupinski J, Pongrac R, Seliger L, Normandin D, Macor JE..  (2000)  Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitors.,  43  (26): [PMID:11150175] [10.1021/jm000336j]

Source